Treatment options for patients with epithelioid hemangioendothelioma vary dependent on disease status, but more therapies are ...

Combining two cancer immunotherapeutics – Bristol-Myers Squibb's Opdivo and Yervoy – has achieved unprecedented efficacy in a landmark melanoma study.